Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124667344 | 12466734 | 4 | F | 20160722 | 20160615 | 20160802 | EXP | GB-MHRA-ADR 23507230 | GB-ACCORD-041595 | ACCORD | 41.00 | YR | F | Y | 0.00000 | 20160802 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124667344 | 12466734 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | U | 202593 | ||||||||||
124667344 | 12466734 | 2 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | U | 11811 | ||||||||||
124667344 | 12466734 | 3 | SS | TYVERB | LAPATINIB | 1 | Unknown | U | 0 | ||||||||||
124667344 | 12466734 | 4 | SS | DOXYCYCLINE. | DOXYCYCLINE | 1 | Unknown | U | 0 | ||||||||||
124667344 | 12466734 | 5 | SS | CLEXANE | ENOXAPARIN SODIUM | 1 | Subcutaneous | U | 0 | INJECTION | |||||||||
124667344 | 12466734 | 6 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Subcutaneous | U | 0 | ||||||||||
124667344 | 12466734 | 7 | SS | LOPERAMIDE | LOPERAMIDE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124667344 | 12466734 | 1 | Product used for unknown indication |
124667344 | 12466734 | 2 | Product used for unknown indication |
124667344 | 12466734 | 3 | Product used for unknown indication |
124667344 | 12466734 | 4 | Acne |
124667344 | 12466734 | 5 | Product used for unknown indication |
124667344 | 12466734 | 6 | Product used for unknown indication |
124667344 | 12466734 | 7 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124667344 | 12466734 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124667344 | 12466734 | Abasia | |
124667344 | 12466734 | Acne | |
124667344 | 12466734 | Anxiety | |
124667344 | 12466734 | Contusion | |
124667344 | 12466734 | Depression | |
124667344 | 12466734 | Diarrhoea | |
124667344 | 12466734 | Dyspnoea | |
124667344 | 12466734 | Eating disorder | |
124667344 | 12466734 | Fatigue | |
124667344 | 12466734 | Gastritis | |
124667344 | 12466734 | Headache | |
124667344 | 12466734 | Inflammatory pain | |
124667344 | 12466734 | Insomnia | |
124667344 | 12466734 | Muscle spasms | |
124667344 | 12466734 | Onychalgia | |
124667344 | 12466734 | Oropharyngeal pain | |
124667344 | 12466734 | Pain in extremity | |
124667344 | 12466734 | Peripheral swelling | |
124667344 | 12466734 | Plantar erythema | |
124667344 | 12466734 | Pruritus | |
124667344 | 12466734 | Speech disorder | |
124667344 | 12466734 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124667344 | 12466734 | 4 | 20160324 | 0 |